Pangea

The next revolution in precision oncology - Pangea Biomed

Tel Aviv, Israel · Founded 2018 · $12.0M raised

Headquarters
Tel Aviv
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$12.0M
Last Round
$5.0M SeedDec 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Pangea Biomed redefines cancer care by combining molecular biology technology with bioinformatics and machine learning. The company aims to accelerate drug discovery, achieve highly personalized treatment nomination for every patient, and improve clinical efficiency and outcomes. ENLIGHT, its proprietary tumor intelligence platform, looks beyond actionable genomic abnormalities by examining the molecular context in which targeted therapies operate and considering expression abnormalities that are orders of magnitude more common than actionable mutations.

Summary

Pangea is a Biotech company based in Tel Aviv, Israel, founded in 2018. It has raised $12.0M in total across 2 rounds, most recently a $5.0M Seed round in Dec 2022.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedDec 2022
$5.0M

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pangea on Indexed.vc
<a href="https://indexed.vc/companies/pangea"><img src="https://indexed.vc/api/badge/company/pangea" alt="Pangea on Indexed.vc" width="260" height="76" /></a>